2025001-CRHA-132II參考文獻(xiàn)ADDINZOTERO_BIBL{"uncited":[],"omitted":[],"custom":[]}CSL_BIBLIOGRAPHY[1] 中華醫(yī)學(xué)會內(nèi)分泌分會,中華醫(yī)學(xué)會外科學(xué)分會甲狀腺及代謝外科學(xué)組,中國抗癌協(xié)會頭頸腫瘤專業(yè)委員會,等.甲狀腺結(jié)節(jié)和分化型甲狀腺癌診治指南(第二版)[J].中華內(nèi)分泌代謝雜志,2023,39(3):181-226.【請重新確認(rèn)文獻(xiàn)參考類型】[2] 田文,孫輝,賀青卿.超聲引導(dǎo)下甲狀腺結(jié)節(jié)細(xì)針穿刺活檢專家共識及操作指南(2018版)[J].中國實用外科雜志,2018,38(03):241-244.[3] 國家癌癥中心,國家腫瘤質(zhì)控中心甲狀腺癌質(zhì)控專家委員會.中國甲狀腺癌規(guī)范診療質(zhì)量控制指標(biāo)(2022版)[J].中華腫瘤雜志,2022,44(09):902-907.【請重新確認(rèn)文獻(xiàn)信息準(zhǔn)確性，無法檢索到該文獻(xiàn)】[4] 郭又銘,霍金龍,瞿銳,等.無負(fù)壓對比負(fù)壓細(xì)針穿刺在甲狀腺結(jié)節(jié)中比較的Meta分析[J].臨床耳鼻咽喉頭頸外科雜志,2018,32(11):868-872.[5] HsiaoV,MassoudE,JensenC,etal.DiagnosticAccuracyofFine-NeedleBiopsyintheDetectionofThyroidMalignancy[J].JAMASurgery,2022,157(12):1105.【請補全文獻(xiàn)名稱】[6] 中華人民共和國國家衛(wèi)生健康委員會醫(yī)政醫(yī)管局.甲狀腺癌診療指南（2022年版）[J].中國實用外科雜志,2022,42(12):1343-1357+1363.[7] HaugenBR,AlexanderEK,BibleKC,etal.2015AmericanThyroidAssociationManagementGuidelinesforAdultPatientswithThyroidNodulesandDifferentiatedThyroidCancer:TheAmericanThyroidAssociationGuidelinesTaskForceonThyroidNodulesandDifferentiatedThyroidCancer[J].Thyroid,2016,26(1):1-133.【請重新確認(rèn)文獻(xiàn)信息準(zhǔn)確性，無法檢索到該文獻(xiàn)】[8] NationalComprehensiveCancerNetwork.ThyroidCarcinoma,Version4.2024,NCCNClinicalPracticeGuidelinesinOncology[EB/OL].(2024)./.【鏈接請具體至具體網(wǎng)頁，而非官網(wǎng)頁面的網(wǎng)址】[9] 中華醫(yī)學(xué)會病理學(xué)分會細(xì)胞病理學(xué)組.甲狀腺細(xì)針穿刺細(xì)胞病理學(xué)診斷專家共識（2023版）[J].中華病理學(xué)雜志,2023,52(5):441-446.【請重新確認(rèn)文獻(xiàn)信息準(zhǔn)確性，無法檢索到該文獻(xiàn)】[10] AliSZ,BalochZW,Cochand-PriolletB,etal.The2023BethesdaSystemforReportingThyroidCytopathology[J].Thyroid,2023,33(9):1039-1044.【請重新確認(rèn)文獻(xiàn)信息準(zhǔn)確性，無法檢索到該文獻(xiàn)】[11] GraniG,SponzielloM,FilettiS,etal.Thyroidnodules:diagnosisandmanagement[J].NatureReviewsEndocrinology,2024.【請重新確認(rèn)文獻(xiàn)信息準(zhǔn)確性，無法檢索到該文獻(xiàn)，并且補全文獻(xiàn)卷號、期號、頁碼范圍】[12] PaschkeR,CantaraS,CrescenziA,etal.EuropeanThyroidAssociationGuidelinesregardingThyroidNoduleMolecularFine-NeedleAspirationCytologyDiagnostics[J].EuropeanThyroidJournal,2017,6(3):115-129.[13] FumagalliC,SerioG.Moleculartestinginindeterminatethyroidnodules:anadditionaltoolforclinicaldecision-making[J].Pathologica,2023,115(4):205-216.[14] 羅定遠(yuǎn),廖健偉.甲狀腺癌基因檢測與臨床應(yīng)用廣東專家共識(2020版)[J].中華普通外科學(xué)文獻(xiàn)(電子版),2020,14(3):161-168.【建議修改為電子文獻(xiàn)，不用“J”】[15] 張帥,周樂.甲狀腺結(jié)節(jié)性質(zhì)診斷的細(xì)針穿刺洗脫液檢查研究進(jìn)展[J].中國實驗診斷學(xué),2024,28(5):594-598.[16] ZhuX,ZhouJ,QianY,etal.Diagnosticvaluesofthyroglobulininlymphnodefine-needleaspirationwashout:asystematicreviewandmeta-analysisdiagnosticvaluesofFNA-Tg[J].EndocrineJournal,2020,67(2):113-123.[17] 徐成,王璐璐,王少華.洗脫液甲狀腺球蛋白在甲狀腺乳頭狀癌轉(zhuǎn)移淋巴結(jié)中的應(yīng)用[J].中華普外科手術(shù)學(xué)雜志（電子版）,2023,17(6):701-704.【建議修改為電子文獻(xiàn)，不用“J”】[18] LiuQ,MaoL,ZhangZ,etal.DiagnosticEfficacyofFNA-TginDTCCervicalLNMetastasisanditsImpactFactors:ALargeRetrospectiveStudy[J].TheJournalofClinicalEndocrinology&Metabolism,2023,108(12):3311-3319.[19] 中華醫(yī)學(xué)會超聲醫(yī)學(xué)分會淺表器官和血管學(xué)組,中國甲狀腺與乳腺超聲人工智能聯(lián)盟.2020甲狀腺結(jié)節(jié)超聲惡性危險分層中國指南：C-TIRADS[J].中華超聲影像學(xué)雜志,2021,30(03):185-200.【請重新確認(rèn)文獻(xiàn)信息準(zhǔn)確性，無法檢索到該文獻(xiàn)】[20] 中國醫(yī)師協(xié)會介入醫(yī)師分會超聲介入專業(yè)委員會.超聲引導(dǎo)下甲狀腺結(jié)節(jié)及頸部淋巴結(jié)穿刺專家共識（2023版）[J].中華內(nèi)科雜志,2024,63(06):550-559.【請重新確認(rèn)文獻(xiàn)信息準(zhǔn)確性，無法檢索到該文獻(xiàn)】[21] 中國超聲醫(yī)學(xué)工程學(xué)會淺表器官及外周血管專業(yè)委員會.甲狀腺及相關(guān)頸部淋巴結(jié)超聲若干臨床常見問題專家共識(2018版)[J].中國超聲醫(yī)學(xué)雜志,2019,35(3):193-204.[22] 中華醫(yī)學(xué)會內(nèi)分泌學(xué)分會,中華醫(yī)學(xué)會圍產(chǎn)醫(yī)學(xué)分會.妊娠和產(chǎn)后甲狀腺疾病診治指南(第2版)[J].中華內(nèi)分泌代謝雜志,2019,35(8):636-665.【建議將年份修改為2020年】[23] 張帥,付慶鋒,何潤東,等.超聲引導(dǎo)下重復(fù)細(xì)針穿刺活檢術(shù)對BethesdaⅢ類甲狀腺結(jié)節(jié)臨床管理的影響[J].中華內(nèi)分泌外科雜志,2024,18(4):489-493.【請重新確認(rèn)文獻(xiàn)信息準(zhǔn)確性，無法檢索到該文獻(xiàn)】[24] TrimboliP,D’AurizioF,TozzoliR,et.al.Measurementofthyroglobulin,calcitonin,andPTHinFNAwashoutfluids[J].ClinicalChemistryandLaboratoryMedicine,2017,55(7).【請重新確認(rèn)文獻(xiàn)信息準(zhǔn)確性，無法檢索到該文獻(xiàn)】[25] 林又佳,薛恩生,林禮務(wù),等.超聲引導(dǎo)FNAC聯(lián)合FNA-Tg測定對DTC術(shù)前頸部淋巴結(jié)轉(zhuǎn)移的診斷價值[J].中國超聲醫(yī)學(xué)雜志,2021,37(6):614-617.[26] KahramangilB,KoseE,DonmezM,etal.Thyroglobulinwashoutfromcervicallymphnodefineneedleaspirationbiopsiesinpatientswithdifferentiatedthyroidcancer:ananalysisofdifferentexpressionstouseinpost-totalthyroidectomyfollow-up[J].Surgery,2020,167(1):34-39.[27] LiW,DimD,PaulsonL,etal.Diagnosisofintrathyroidalectopicthymusinthyroidfineneedleaspirationsamples[J].JournalofClinicalPathology,2019,72(2):145-151.[28] CavalloAC,PitoiaF,RobertiJ,etal.OptimizingDiagnosticAccuracyofFineNeedleAspirationBiopsyCalcitoninMeasurementsinDetectingMedullaryThyroidCarcinoma[J].Thyroid,2024,34(2):186-196.【請重新確認(rèn)文獻(xiàn)信息準(zhǔn)確性，無法檢索到該文獻(xiàn)】[29] TrimboliP,GiannelliJ,MarquesB,etal.Head-to-headcomparisonofFNAcytologyvs.calcitoninmeasurementinFNAwashoutfluids(FNA-CT)todiagnosemedullarythyroidcarcinoma.Asystematicreviewandmeta-analysis[J].Endocrine,2022,75(1):33-39.[30] MarquesB,CunhaN,MartinsRG,etal.LymphNodeMetastasesofMedullaryThyroidCancer:RoleofCalcitoninintheWashoutFluidofFine-NeedleAspiration[J].InternationalJournalofEndocrinology,2020,2020:1-6.[31] G?K?AYCANPOLATA,?AH?NM,CEYHANK,etal.Calcitoninlevelsinwashoutsamplesvs.cytologyinthedetectionofmalignantlymphnodemetastasisinrecurrentmedullarythyroidcancer[J].TURKISHJOURNALOFMEDICALSCIENCES,2021,51(6):3061-3066.【請重新確認(rèn)文獻(xiàn)信息準(zhǔn)確性，無法檢索到該文獻(xiàn)】[32] MikosińskiP,Wo?owiec-KoreckaE,PomorskiL,etal.Cut-offValueforThyroglobulinWashoutConcentrationintheDetectionofCervicalLymphNodeMetastasesinPatientsafterThyroidectomyDuetoDifferentiatedThyroidCancer[J].Biomedicines,2023,11(9):2433.【請重新確認(rèn)文獻(xiàn)信息準(zhǔn)確性，無法檢索到該文獻(xiàn)】[33] JeonMJ,KimWG,JangEK,etal.ThyroglobulinLevelinFine-NeedleAspiratesforPreoperativeDiagnosisofCervicalLymphNodeMetastasisinPatientswithPapillaryThyroidCarcinoma:TwoDifferentCutoffValuesAccordingtoSerumThyroglobulinLevel[J].Thyroid,2015,25(4):410-416.[34] MoonJH,KimYI,LimJA,etal.ThyroglobulininWashoutFluidFromLymphNodeFine-needleAspirationBiopsyinPapillaryThyroidCancer:Large-scaleValidationoftheCutoffValuetoDetermineMalignancyandEvaluationofDiscrepantResults[J].JournalofClinicalEndocrinology&Metabolism,2013,98(3):1061-1068.【請重新確認(rèn)文獻(xiàn)信息準(zhǔn)確性，無法檢索到該文獻(xiàn)】[35] 付慶鋒,周樂,邊學(xué)海,等.甲狀腺乳頭狀癌頸部淋巴結(jié)轉(zhuǎn)移FNA-Tg診斷標(biāo)準(zhǔn)值的探討[J].中華內(nèi)分泌外科雜志,2013,7(2):154-156.【請重新確認(rèn)文獻(xiàn)信息準(zhǔn)確性，無法檢索到該文獻(xiàn)】[36] ZhangX,HowellJM,HuangY.CervicalLymphNodeFine-NeedleAspirationandNeedle-WashThyroglobulinReflexTestforPapillaryThyroidCarcinoma[J].EndocrinePathology,2018,29(4):346-350.[37] HuangY,ChanSJ,WrightJD,etal.DoestheAdoptionofMolecularTestingCauseDecreasedThyroidectomyRatesinaNationalCohort?AQuasiexperimentalStudyofHigh-VersusLow-AdoptionStates[J].Thyroid,2024,34(3):388-398.[38] NgoHTT,NguyenTPX,VuTH,etal.ImpactofMolecularTestingontheManagementofIndeterminateThyroidNodulesAmongWesternandAsianCountries:aSystematicReviewandMeta-analysis[J].EndocrinePathology,2021,32(2):269-279.【請重新確認(rèn)文獻(xiàn)信息準(zhǔn)確性，無法檢索到該文獻(xiàn)】[39] StewardsonP,EszlingerM,WuJ,etal.ProspectiveValidationofThyroSPECMolecularTestingofIndeterminateThyroidNoduleCytologyFollowingDiagnosticPathwayOptimization[J].Thyroid,2023,33(12):1423-1433.【請重新確認(rèn)文獻(xiàn)信息準(zhǔn)確性，無法檢索到該文獻(xiàn)】[40] KimNE,RaghunathanRS,HughesEG,etal.BethesdaIIIandIVThyroidNodulesManagedNonoperativelyAfterMolecularTestingWithAfirmaGSCorThyroseqv3[J].JournalofClinicalEndocrinology&Metabolism,2023,108(9):e698-e703.[41] JiangM,YuY,YangA.ConcernsRegardingThermalAblationforPapillaryThyroidCancer[J].JAMASurgery,2024.【請補全期號、刊號、頁碼范圍】[42] 嵇慶海,程若川,田文.對《甲狀腺乳頭狀癌熱消融治療專家共識（2024版）》部分內(nèi)容的探討[J].中華耳鼻咽喉頭頸外科雜志,2024,59(10):1088-1093.【請重新確認(rèn)文獻(xiàn)信息準(zhǔn)確性，無法檢索到該文獻(xiàn)】[43] GraniG,SponzielloM,FilettiS,etal.Thyroidnodules:diagnosisandmanagement[J].NatureReviewsEndocrinology,2024.【請補全期號、刊號、頁碼范圍】[44] SchummMA,ShuML,HughesEG,etal.PrognosticValueofPreoperativeMolecularTestingandImplicationsforInitialSurgicalManagementinThyroidNodulesHarboringSuspected(BethesdaV)orKnown(BethesdaVI)PapillaryThyroidCancer[J].JAMAOtolaryngology–Head&NeckSurgery,2023,149(8):735-742.【請重新確認(rèn)文獻(xiàn)信息準(zhǔn)確性，無法檢索到該文獻(xiàn)】[45] LiuJB,BaughKA,RamonellKM,etal.MolecularTestingPredictsIncompleteResponsetoInitialTherapyinDifferentiatedThyroidCarcinomaWithoutLateralNeckorDistantMetastasisatPresentation:RetrospectiveCohortStudy[J].Thyroid,2023,33(6):705-714.[46] KustD,Stani?i?J,Mate?aN,etal.Bethesdathyroidcategoriesandfamilyhistoryofthyroiddisease[J].ClinicalEndocrinology,2018,88(3):468-472.【請重新確認(rèn)文獻(xiàn)信息準(zhǔn)確性，無法檢索到該文獻(xiàn)】[47] 中國抗癌協(xié)會家族遺傳性腫瘤專業(yè)委員會.中國家族遺傳性腫瘤臨床診療專家共識（2021年版）（5）——家族遺傳性甲狀腺癌[J].中國腫瘤臨床,2022,49(1):6-11.[48] FuG,ChazenRS,MonteiroE,etal.FacilitationofDefinitiveCancerDiagnosisWithQuantitativeMolecularAssaysofBRAFV600EandTERTPromoterVariantsinPatientsWithThyroidNodules[J].JAMANetworkOpen,2023,6(7):e2323500.【請補全文獻(xiàn)名稱】[49] MoonS,SongYS,KimYA,etal.EffectsofCoexistentBRAFV600EandTERTPromoterMutationsonPoorClinicalOutcomesinPapillaryThyroidCancer:AMeta-Analysis[J].Thyroid,2017,27(5):651-660.【請補全文獻(xiàn)名稱】[50] GallantJ-N,ChenS-C,OrtegaCA,etal.EvaluationoftheMolecularLandscapeofPediatricThyroidNodulesandUseofaMultigeneGenomicClassifierinChildren[J].JAMAOncology,2022,8(9):1323.【單頁文獻(xiàn)不建議引用，領(lǐng)域經(jīng)典和前沿發(fā)現(xiàn)除外】[51] StewardDL,CartySE,SippelRS,etal.PerformanceofaMultigeneGenomicClassifierinThyroidNodulesWithIndeterminateCytology[J].JAMAOncology,2019,5(2):204-212.【補全文獻(xiàn)名稱】[52] 羅定遠(yuǎn),廖健偉.甲狀腺癌RET基因檢測與臨床應(yīng)用專家共識（2021版）[J].中華普通外科學(xué)文獻(xiàn)(電子版),2022,16(1):1-8.[53] BarlettaJA,NoséV,SadowPM.GenomicsandEpigenomicsofMedullaryThyroidCarcinoma:FromSporadicDiseasetoFamilialManifestations[J].EndocrinePathology,2021,32(1):35-43.【請重新確認(rèn)文獻(xiàn)信息準(zhǔn)確性，無法檢索到該文獻(xiàn)】[54] 殷德濤.實用甲狀腺疾病診療——甲狀腺結(jié)節(jié)細(xì)針穿刺活檢術(shù)[M].河南:鄭州大學(xué)出版社,2021.[55] 孫輝,周樂.實用甲狀腺結(jié)節(jié)細(xì)針穿刺活檢技術(shù)[M].吉林:吉林科學(xué)技術(shù)出版社,2018.【請重新確認(rèn)文獻(xiàn)信息準(zhǔn)確性，無法檢索到該文獻(xiàn)】[56] 周樂,張廣,張大奇,等.超聲引導(dǎo)下甲狀腺結(jié)節(jié)細(xì)針穿刺活檢臨床應(yīng)用及質(zhì)量控制研究[J].中國實用外科雜志,2015,35(6):650-652.[57] 章建全,陳紅瓊,閆磊,等.對甲狀腺結(jié)節(jié)細(xì)針穿刺有關(guān)問題的新思考[J].中華醫(yī)學(xué)超聲雜志（電子版）,2024,20(10):1007-1011.【請重新確認(rèn)文獻(xiàn)信息準(zhǔn)確性，無法檢索到該文獻(xiàn)】[58] LvT,MaW,TanZ,etal.LevelIIlateralneckdissectionforpapillarythyroidcarcinoma:Aretrospectivecohortstudy[J].Asia